| Intermission: Point and click tricks
Digital cameras revolutionized the way that we photograph the world. Where once we might have asked a stranger to take a photo of us, we now extend our arms and direct the lens at our face before opening the shutter. Once we hear the synthetic “click" of a closed shutter, we flip the camera around to view the photograph on the LCD screen to decide if another take is necessary. It's the digital self-portrait, and it is unavoidable on Facebook. It has become such a symbol for the way we share ourselves with the virtual world that it has been absorbed by marketers as a means of conveying modernity (for proof of this, look no further than the poster for “Marie Antoinette"). .
Bradley Pharmaceuticals 2007 Third Quarter Results
FAIRFIELD, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, (Nachrichten) Inc. announced today that it has filed with the Securities and Exchange Commission its Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. Third Quarter of 2007 -- Launched ADOXA(R) 150mg capsules. -- Paid outstanding principal balance of $62.4 million under old credit facility on August 3, 2007 with existing cash and cash equivalents, concurrently with entering into a new credit facility and wrote-off deferred financing costs of $3.3 million related to old facility. -- On October 29, 2007, the Company entered into a definitive merger agreement with Nycomed US Inc. Bradley reported that net sales for the quarter ended September 30, 2007 were approximately $33.6 million, a decrease of $1.6 million, or 5%, from net sales of $35.2 million for the quarter ended September 30, 2006.
Medicis revenue climbs 45%
Despite new competition for Restylane, its star performer, Scottsdale drug maker and marketer Medicis boosted revenue 45 percent in the quarter that ended Sept. 30 compared with third-quarter 2006 numbers. The companys bottom line got a big boost from two relatively new acne products, Solodyn and Ziana, CEO Jonah Shacknai said Wednesday in a conference call with analysts. And wrinkle-filler Restylane continued to be a strong market leader even though Medicis rival Allergan launched a similar product earlier this year. Shacknai credited TV commercials and other direct-to-customer marketing with significantly boosting Restylane Web traffic and creating new business. The short-term future looks so good Shacknai upped annual earnings estimates to $1.22 from the $1.12 he predicted at the beginning of the year.
|
